OpenClinica
Founded 2004 · 76 employees on LinkedIn · 1 known investors
OpenClinica eConsent is a digital consent platform for clinical trials that enables participants to review and electronically sign informed consent forms using media-rich content on any device. It serves academic researchers, sponsors, contract research organizations (CROs), and clinical trial sites who need to streamline enrollment while maintaining regulatory compliance across decentralized, hybrid, and in-person studies.
Founders & leadership
OpenClinica was founded in 2004 by Joe Keremian.
JK
Joe KeremianinFounder
Investors · 1
Frequently asked questions
- What does OpenClinica do?
- OpenClinica eConsent is a digital consent platform for clinical trials that enables participants to review and electronically sign informed consent forms using media-rich content on any device. It serves academic researchers, sponsors, contract research organizations (CROs), and clinical trial sites who need to streamline enrollment while maintaining regulatory compliance across decentralized, hybrid, and in-person studies.
- Who founded OpenClinica?
- OpenClinica was founded by Joe Keremian in 2004.
- Who are OpenClinica's investors?
- OpenClinica's investors include Thompson Street Capital Partners.